We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+24.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$589M
Cap. Flow %
4.16%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Industrials 12.27%
4 Healthcare 11.72%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORRF icon
926
Orrstown Financial Services
ORRF
$810M
$36 ﹤0.01%
+1
New +$36
CNNE icon
927
Cannae Holdings
CNNE
$646M
$34 ﹤0.01%
+3
New +$40
ONON icon
928
On Holding
ONON
$12.4B
$34 ﹤0.01%
+1
New +$44
LOB icon
929
Live Oak Bancshares
LOB
$1.93B
$33 ﹤0.01%
+1
New +$37
CENTA icon
930
Central Garden & Pet Co Class A
CENTA
$2.38B
$32 ﹤0.01%
+1
New +$32
PZZA icon
931
Papa John's
PZZA
$1.06B
$32 ﹤0.01%
+1
New +$35
BBT
932
Beacon Financial Corp
BBT
$2.56B
$30 ﹤0.01%
1
-27,611
-100% -$806K
VIA
933
Via Transportation Inc
VIA
$1.51B
$30 ﹤0.01%
2
-399,998
-100% -$7.98M
AXTA icon
934
Axalta
AXTA
$6.95B
$28 ﹤0.01%
+1
New +$32
MMI icon
935
Marcus & Millichap
MMI
$1.16B
$27 ﹤0.01%
+1
New +$26
INGM
936
Ingram Micro Holding
INGM
$6.79B
$23 ﹤0.01%
+1
New +$22
HOPE icon
937
Hope Bancorp
HOPE
$1.75B
$22 ﹤0.01%
+2
New +$23
LENZ
938
LENZ Therapeutics
LENZ
$162M
$18 ﹤0.01%
2
-22,969
-100% -$323K
HNRG icon
939
Hallador Energy
HNRG
$783M
$16 ﹤0.01%
+1
New +$19
SPRY icon
940
ARS Pharmaceuticals
SPRY
$632M
$16 ﹤0.01%
2
-28,001
-100% -$268K
HAPN
941
Happen Inc
HAPN
$2.2B
$14 ﹤0.01%
+1
New +$17
WULF icon
942
TeraWulf
WULF
$9.85B
$14 ﹤0.01%
+1
New +$15
BMBL icon
943
Bumble
BMBL
$374M
$13 ﹤0.01%
4
-13,073
-100% -$43.5K
SAIL
944
SailPoint Inc
SAIL
$8.38B
$13 ﹤0.01%
1
-499,999
-100% -$7.8M
GEMI
945
Gemini Space Station
GEMI
$603M
$13 ﹤0.01%
+3
New +$24
BV icon
946
BrightView Holdings
BV
$1.31B
$12 ﹤0.01%
+1
New +$13
HTBK
947
DELISTED
Heritage Commerce
HTBK
$12 ﹤0.01%
+1
New +$13
XNCR icon
948
Xencor
XNCR
$1.52B
$12 ﹤0.01%
+1
New +$12
IART icon
949
Integra LifeSciences
IART
$1.48B
$9 ﹤0.01%
+1
New +$11
UPB
950
Upstream Bio Inc
UPB
$380M
$9 ﹤0.01%
+1
New +$18

Similar funds

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.